{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:05:01Z","timestamp":1718409901933},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,2,2]],"date-time":"2016-02-02T00:00:00Z","timestamp":1454371200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,2,2]],"date-time":"2016-02-02T00:00:00Z","timestamp":1454371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1038\/gt.2016.7","type":"journal-article","created":{"date-parts":[[2016,2,2]],"date-time":"2016-02-02T16:20:29Z","timestamp":1454430029000},"page":"408-414","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The induction of antigen-specific CTL by in situ Ad-REIC gene therapy"],"prefix":"10.1038","volume":"23","author":[{"given":"Y","family":"Ariyoshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Eikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Sadahira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Araki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Ebara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Nasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Udono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Kumon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,2]]},"reference":[{"key":"BFgt20167_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1006\/bbrc.1999.2067","volume":"268","author":"T Tsuji","year":"2000","unstructured":"Tsuji T, Miyazaki M, Sakaguchi M, Inoue Y, Namba M . A REIC gene shows down-regulation in human immortalized cells and human tumor-derived cell lines. Biochem Biophys Res Commun 2000; 268: 20\u201324.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFgt20167_CR2","first-page":"18","volume":"1825","author":"J Veeck","year":"2012","unstructured":"Veeck J, Dahl E . Targeting the Wnt pathway in cancer: the emerging role of Dickkopf-3. Biochim Biophys Acta 2012; 1825: 18\u201328.","journal-title":"Biochim Biophys Acta"},{"key":"BFgt20167_CR3","first-page":"117","volume":"19","author":"I Nozaki","year":"2001","unstructured":"Nozaki I, Tsuji T, Iijima O, Ohmura Y, Andou A, Miyazaki M et al. Reduced expression of REIC\/Dkk-3 gene in non-small cell lung cancer. Int J Oncol 2001; 19: 117\u2013121.","journal-title":"Int J Oncol"},{"key":"BFgt20167_CR4","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1097\/01.ju.0000101047.64379.d4","volume":"171","author":"K Kurose","year":"2004","unstructured":"Kurose K, Sakaguchi M, Nasu Y, Ebara S, Kaku H, Kariyama R et al. Decreased expression of REIC\/Dkk-3 in human renal clear cell carcinoma. J Urology 2004; 171: 1314\u20131318.","journal-title":"J Urology"},{"key":"BFgt20167_CR5","first-page":"775","volume":"14","author":"SY Qin","year":"2006","unstructured":"Qin SY, Liu ZM, Jiang HX, Ge LY, Tao L, Tang GD et al. Detection of reduced mRNA expression of REIC\/Dkk-3 gene in human primary hepatocellular carcinoma. Chin J Hepatol 2006; 14: 775\u2013776.","journal-title":"Chin J Hepatol"},{"key":"BFgt20167_CR6","doi-asserted-by":"publisher","first-page":"5027","DOI":"10.1038\/sj.onc.1209508","volume":"25","author":"S Kuphal","year":"2006","unstructured":"Kuphal S, Lodermeyer S, Bataille F, Schuierer M, Hoang BH, Bosserhoff AK . Expression of Dickkopf genes is strongly reduced in malignant melanoma. Oncogene 2006; 25: 5027\u20135036.","journal-title":"Oncogene"},{"key":"BFgt20167_CR7","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3109\/08977191003738832","volume":"28","author":"RE Nakamura","year":"2010","unstructured":"Nakamura RE, Hackam AS . Analysis of Dickkopf3 interactions with Wnt signaling receptors. Growth Factors (Chur, Switzerland) 2010; 28: 232\u2013242.","journal-title":"Growth Factors (Chur, Switzerland)"},{"key":"BFgt20167_CR8","doi-asserted-by":"publisher","first-page":"e63603","DOI":"10.1371\/journal.pone.0063603","volume":"8","author":"DS Das","year":"2013","unstructured":"Das DS, Wadhwa N, Kunj N, Sarda K, Pradhan BS, Majumdar SS . Dickkopf homolog 3 (DKK3) plays a crucial role upstream of WNT\/beta-CATENIN signaling for Sertoli cell mediated regulation of spermatogenesis. PLoS One 2013; 8: e63603.","journal-title":"PLoS One"},{"key":"BFgt20167_CR9","first-page":"63","volume":"68","author":"Y Fujii","year":"2014","unstructured":"Fujii Y, Hoshino T, Kumon H . Molecular simulation analysis of the structure complex of C2 domains of DKK family members and beta-propeller domains of LRP5\/6: explaining why DKK3 does not bind to LRP5\/6. Acta Med Okayama 2014; 68: 63\u201378.","journal-title":"Acta Med Okayama"},{"key":"BFgt20167_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0925-4773(99)00138-0","volume":"87","author":"AP Monaghan","year":"1999","unstructured":"Monaghan AP, Kioschis P, Wu W, Zuniga A, Bock D, Poustka A et al. Dickkopf genes are co-ordinately expressed in mesodermal lineages. Mech Dev 1999; 87: 45\u201356.","journal-title":"Mech Dev"},{"key":"BFgt20167_CR11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/1471-2164-11-176","volume":"11","author":"J de Wilde","year":"2010","unstructured":"de Wilde J, Hulshof MF, Boekschoten MV, de Groot P, Smit E, Mariman EC . The embryonic genes Dkk3, Hoxd8 Hoxd9 and Tbx1 identify muscle types in a diet-independent and fiber-type unrelated way. BMC Genom 2010; 11: 176.","journal-title":"BMC Genom"},{"key":"BFgt20167_CR12","first-page":"657","volume":"34","author":"M Watanabe","year":"2009","unstructured":"Watanabe M, Kashiwakura Y, Huang P, Ochiai K, Futami J, Li SA et al. Immunological aspects of REIC\/Dkk-3 in monocyte differentiation and tumor regression. Int J Oncol 2009; 34: 657\u2013663.","journal-title":"Int J Oncol"},{"key":"BFgt20167_CR13","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.3892\/or.2015.3885","volume":"33","author":"R Kinoshita","year":"2015","unstructured":"Kinoshita R, Watanabe M, Huang P, Li SA, Sakaguchi M, Kumon H et al. The cysteine-rich core domain of REIC\/Dkk-3 is critical for its effect on monocyte differentiation and tumor regression. Oncol Rep 2015; 33: 2908\u20132914.","journal-title":"Oncol Rep"},{"key":"BFgt20167_CR14","doi-asserted-by":"publisher","first-page":"9617","DOI":"10.1158\/0008-5472.CAN-05-0829","volume":"65","author":"F Abarzua","year":"2005","unstructured":"Abarzua F, Sakaguchi M, Takaishi M, Nasu Y, Kurose K, Ebara S et al. Adenovirus-mediated overexpression of REIC\/Dkk-3 selectively induces apoptosis in human prostate cancer cells through activation of c-Jun-NH2-kinase. Cancer Res 2005; 65: 9617\u20139622.","journal-title":"Cancer Res"},{"key":"BFgt20167_CR15","first-page":"363","volume":"19","author":"R Tanimoto","year":"2007","unstructured":"Tanimoto R, Abarzua F, Sakaguchi M, Takaishi M, Nasu Y, Kumon H et al. REIC\/Dkk-3 as a potential gene therapeutic agent against human testicular cancer. Int J Mol Med 2007; 19: 363\u2013368.","journal-title":"Int J Mol Med"},{"key":"BFgt20167_CR16","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/gt.2014.100","volume":"22","author":"Y Shimazu","year":"2014","unstructured":"Shimazu Y, Kurozumi K, Ichikawa T, Fujii K, Onishi M, Ishida J et al. Integrin antagonist augments the therapeutic effect of adenovirus-mediated REIC\/Dkk-3 gene therapy for malignant glioma. Gene Therapy 2014; 22: 146\u2013154.","journal-title":"Gene Therapy"},{"key":"BFgt20167_CR17","doi-asserted-by":"publisher","first-page":"e87900","DOI":"10.1371\/journal.pone.0087900","volume":"9","author":"K Shien","year":"2014","unstructured":"Shien K, Tanaka N, Watanabe M, Soh J, Sakaguchi M, Matsuo K et al. Anti-cancer effects of REIC\/Dkk-3-encoding adenoviral vector for the treatment of non-small cell lung cancer. PLoS One 2014; 9: e87900.","journal-title":"PLoS One"},{"key":"BFgt20167_CR18","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1111\/jgh.12501","volume":"29","author":"D Uchida","year":"2014","unstructured":"Uchida D, Shiraha H, Kato H, Nagahara T, Iwamuro M, Kataoka J et al. Potential of adenovirus-mediated REIC\/Dkk-3 gene therapy for use in the treatment of pancreatic cancer. J Gastroenterol Hepatol 2014; 29: 973\u2013983.","journal-title":"J Gastroenterol Hepatol"},{"key":"BFgt20167_CR19","doi-asserted-by":"publisher","first-page":"8333","DOI":"10.1158\/0008-5472.CAN-08-0080","volume":"68","author":"Y Kashiwakura","year":"2008","unstructured":"Kashiwakura Y, Ochiai K, Watanabe M, Abarzua F, Sakaguchi M, Takaoka M et al. Down-regulation of inhibition of differentiation-1 via activation of activating transcription factor 3 and Smad regulates REIC\/Dickkopf-3-induced apoptosis. Cancer Res 2008; 68: 8333\u20138341.","journal-title":"Cancer Res"},{"key":"BFgt20167_CR20","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1002\/ijc.24764","volume":"126","author":"R Tanimoto","year":"2010","unstructured":"Tanimoto R, Sakaguchi M, Abarzua F, Kataoka K, Kurose K, Murata H et al. Down-regulation of BiP\/GRP78 sensitizes resistant prostate cancer cells to gene-therapeutic overexpression of REIC\/Dkk-3. Int J Cancer 2010; 126: 1562\u20131569.","journal-title":"Int J Cancer"},{"key":"BFgt20167_CR21","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/978-1-4614-0254-1_17","volume":"720","author":"M Sakaguchi","year":"2011","unstructured":"Sakaguchi M, Huh NH, Namba M . A novel tumor suppressor, REIC\/Dkk-3 gene identified by our in vitro transformation model of normal human fibroblasts works as a potent therapeutic anti-tumor agent. Adv Exp Med Biol 2011; 720: 209\u2013215.","journal-title":"Adv Exp Med Biol"},{"key":"BFgt20167_CR22","doi-asserted-by":"publisher","first-page":"14236","DOI":"10.1074\/jbc.M808002200","volume":"284","author":"M Sakaguchi","year":"2009","unstructured":"Sakaguchi M, Kataoka K, Abarzua F, Tanimoto R, Watanabe M, Murata H et al. Overexpression of REIC\/Dkk-3 in normal fibroblasts suppresses tumor growth via induction of interleukin-7. J Biol Chem 2009; 284: 14236\u201314244.","journal-title":"J Biol Chem"},{"key":"BFgt20167_CR23","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3892\/ol.2013.1777","volume":"7","author":"M Watanabe","year":"2014","unstructured":"Watanabe M, Nasu Y, Kumon H . Adenovirus-mediated REIC\/Dkk-3 gene therapy: Development of an autologous cancer vaccination therapy (Review). Oncol Lett 2014; 7: 595\u2013601.","journal-title":"Oncol Lett"},{"key":"BFgt20167_CR24","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1073\/pnas.1417636112","volume":"112","author":"S Eikawa","year":"2015","unstructured":"Eikawa S, Nishida M, Mizukami S, Yamazaki C, Nakayama E, Udono H . Immune-mediated antitumor effect by type 2 diabetes drug, metformin. Proc Natl Acad Sci USA 2015; 112: 1809\u20131814.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt20167_CR25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.coi.2014.04.006","volume":"29","author":"CG Briseno","year":"2014","unstructured":"Briseno CG, Murphy TL, Murphy KM . Complementary diversification of dendritic cells and innate lymphoid cells. Curr Opin Immunol 2014; 29: 69\u201378.","journal-title":"Curr Opin Immunol"},{"key":"BFgt20167_CR26","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1084\/jem.20020295","volume":"196","author":"JM den Haan","year":"2002","unstructured":"den Haan JM, Bevan MJ . Constitutive versus activation-dependent cross-presentation of immune complexes by CD8(+) and CD8(\u2212) dendritic cells in vivo. J Exp Med 2002; 196: 817\u2013827.","journal-title":"J Exp Med"},{"key":"BFgt20167_CR27","doi-asserted-by":"publisher","first-page":"6861","DOI":"10.4049\/jimmunol.178.11.6861","volume":"178","author":"ML del Rio","year":"2007","unstructured":"del Rio ML, Rodriguez-Barbosa JI, Kremmer E, Forster R . CD103\u2212 and CD103+ bronchial lymph node dendritic cells are specialized in presenting and cross-presenting innocuous antigen to CD4+ and CD8+ T cells. J Immunol (Baltimore, MD: 1950) 2007; 178: 6861\u20136866.","journal-title":"J Immunol (Baltimore, MD: 1950)"},{"key":"BFgt20167_CR28","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nri3254","volume":"12","author":"OP Joffre","year":"2012","unstructured":"Joffre OP, Segura E, Savina A, Amigorena S . Cross-presentation by dendritic cells. Nat Rev Immunol 2012; 12: 557\u2013569.","journal-title":"Nat Rev Immunol"},{"key":"BFgt20167_CR29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1476-4598-12-103","volume":"12","author":"DL Bartlett","year":"2013","unstructured":"Bartlett DL, Liu Z, Sathaiah M, Ravindranathan R, Guo Z, He Y et al. Oncolytic viruses as therapeutic cancer vaccines. Mol Cancer 2013; 12: 103.","journal-title":"Mol Cancer"},{"key":"BFgt20167_CR30","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1200\/JCO.2014.58.3377","volume":"33","author":"RH Andtbacka","year":"2015","unstructured":"Andtbacka RH, Kaufman HL, Collichio F, Amatruda T, Senzer N, Chesney J et al. Talimogene laherparepvec improves durable response rate in patients with advanced melanoma. J Clin Oncol 2015; 33: 2780\u20132788.","journal-title":"J Clin Oncol"},{"key":"BFgt20167_CR31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.coviro.2015.03.016","volume":"13","author":"CJ Breitbach","year":"2015","unstructured":"Breitbach CJ, Parato K, Burke J, Hwang TH, Bell JC, Kirn DH . Pexa-Vec double agent engineered vaccinia: oncolytic and active immunotherapeutic. Curr Opin Virol 2015; 13: 49\u201354.","journal-title":"Curr Opin Virol"},{"key":"BFgt20167_CR32","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/sj.cgt.7701071","volume":"14","author":"K Edamura","year":"2007","unstructured":"Edamura K, Nasu Y, Takaishi M, Kobayashi T, Abarzua F, Sakaguchi M et al. Adenovirus-mediated REIC\/Dkk-3 gene transfer inhibits tumor growth and metastasis in an orthotopic prostate cancer model. Cancer Gene Ther 2007; 14: 765\u2013772.","journal-title":"Cancer Gene Ther"},{"key":"BFgt20167_CR33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4137\/CMO.S23252","volume":"9","author":"H Kumon","year":"2015","unstructured":"Kumon H, Sasaki K, Ariyoshi Y, Sadahira T, Ebara S, Hiraki T et al. Ad-REIC gene therapy: promising results in a patient with metastatic CRPC Following Chemotherapy. Clin Med Insights Oncol 2015; 9: 31\u201338.","journal-title":"Clin Med Insights Oncol"},{"key":"BFgt20167_CR34","doi-asserted-by":"publisher","first-page":"849573","DOI":"10.1155\/2015\/849573","volume":"2015","author":"PS de Araujo-Souza","year":"2015","unstructured":"de Araujo-Souza PS, Hanschke SC, Viola JP . Epigenetic control of interferon-gamma expression in CD8 T cells. J Immunol Res 2015; 2015: 849573.","journal-title":"J Immunol Res"},{"key":"BFgt20167_CR35","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.4049\/jimmunol.1000821","volume":"185","author":"T Ichiyanagi","year":"2010","unstructured":"Ichiyanagi T, Imai T, Kajiwara C, Mizukami S, Nakai A, Nakayama T et al. Essential role of endogenous heat shock protein 90 of dendritic cells in antigen cross-presentation. J Immunol (Baltimore, MD: 1950) 2010; 185: 2693\u20132700.","journal-title":"J Immunol (Baltimore, MD: 1950)"},{"key":"BFgt20167_CR36","doi-asserted-by":"publisher","first-page":"16363","DOI":"10.1073\/pnas.1108372108","volume":"108","author":"T Imai","year":"2011","unstructured":"Imai T, Kato Y, Kajiwara C, Mizukami S, Ishige I, Ichiyanagi T et al. Heat shock protein 90 (HSP90) contributes to cytosolic translocation of extracellular antigen for cross-presentation by dendritic cells. Proc Natl Acad Sci USA 2011; 108: 16363\u201316368.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt20167_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.0105-2896.2004.00142.x","volume":"199","author":"WR Heath","year":"2004","unstructured":"Heath WR, Belz GT, Behrens GM, Smith CM, Forehan SP, Parish IA et al. Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol Rev 2004; 199: 9\u201326.","journal-title":"Immunol Rev"},{"key":"BFgt20167_CR38","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/cgt.2008.58","volume":"16","author":"K Kawasaki","year":"2009","unstructured":"Kawasaki K, Watanabe M, Sakaguchi M, Ogasawara Y, Ochiai K, Nasu Y et al. REIC\/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7\/ADR cells and induces apoptosis in breast cancer. Cancer Gene Ther 2009; 16: 65\u201372.","journal-title":"Cancer Gene Ther"},{"key":"BFgt20167_CR39","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3892\/ijo.2012.1503","volume":"41","author":"T Hirata","year":"2012","unstructured":"Hirata T, Watanabe M, Kaku H, Kobayashi Y, Yamada H, Sakaguchi M et al. REIC\/Dkk-3-encoding adenoviral vector as a potentially effective therapeutic agent for bladder cancer. Int J Oncol 2012; 41: 559\u2013564.","journal-title":"Int J Oncol"},{"key":"BFgt20167_CR40","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.3892\/or.2015.3770","volume":"33","author":"K Fujio","year":"2015","unstructured":"Fujio K, Watanabe M, Ueki H, Li SA, Kinoshita R, Ochiai K et al. A vaccine strategy with multiple prostatic acid phosphatase-fused cytokines for prostate cancer treatment. Oncol Rep 2015; 33: 1585\u20131592.","journal-title":"Oncol Rep"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt20167.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt20167","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt20167.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T03:36:07Z","timestamp":1718336167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt20167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,2]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["BFgt20167"],"URL":"https:\/\/doi.org\/10.1038\/gt.2016.7","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,2]]},"assertion":[{"value":"4 August 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Okayama University and Momotaro-Gene Inc. are applying for patents on the Ad-REIC systems. MW, YN and HK are the inventors of the patents and own stock in Momotaro-Gene Inc. The remaining authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}